[Answered] With nonprobability sampling, a researcher is less likely to get a biased sample. Indicate ...

This topic contains a solution. Click here to go to the answer

Author Question: With nonprobability sampling, a researcher is less likely to get a biased sample. Indicate ... (Read 60 times)

rl

Hero Member
Posts: 579

on: Jul 13, 2018

With nonprobability sampling, a researcher is less likely to get a biased sample.

Indicate whether the statement is true or false

Question 2

__________: The unassuming explanation for differences between groups that implies that the differences are accounted for by variables other than those being studied.

Fill in the blanks with correct word

Need homework help now?

Ask unlimited questions for free

Ask a Question

Marked as best answer by a Subject Expert

prumorgan

Sr. Member
Posts: 326

Reply #1 on: Jul 13, 2018

Answer to Question 1

F

Answer to Question 2

Treatment Variable

rl

Member
Posts: 579

Reply 2 on: Jul 13, 2018

Wow, this really help

ghepp

Member
Posts: 361

Reply 3 on: Yesterday

TYSM

« previous next »

Did you know?

In the United States, there is a birth every 8 seconds, according to the U.S. Census Bureau's Population Clock.

Did you know?

Over time, chronic hepatitis B virus and hepatitis C virus infections can progress to advanced liver disease, liver failure, and hepatocellular carcinoma. Unlike other forms, more than 80% of hepatitis C infections become chronic and lead to liver disease. When combined with hepatitis B, hepatitis C now accounts for 75% percent of all cases of liver disease around the world. Liver failure caused by hepatitis C is now leading cause of liver transplants in the United States.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

Did you know?

Before a vaccine is licensed in the USA, the Food and Drug Administration (FDA) reviews it for safety and effectiveness. The CDC then reviews all studies again, as well as the American Academy of Pediatrics and the American Academy of Family Physicians. Every lot of vaccine is tested before administration to the public, and the FDA regularly inspects vaccine manufacturers' facilities.

Did you know?

Chronic necrotizing aspergillosis has a slowly progressive process that, unlike invasive aspergillosis, does not spread to other organ systems or the blood vessels. It most often affects middle-aged and elderly individuals, spreading to surrounding tissue in the lungs. The disease often does not respond to conventionally successful treatments, and requires individualized therapies in order to keep it from becoming life-threatening.